InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,185.14
(
-0.05%
)
US TECH 100
17,590.80
(
-0.12%
)
Dow Jones
39,032.84
(
0.38%
)
Brent Oil
83.55
(
0.82%
)
Bitcoin
62,316.32
(
-0.03%
)
Post# of 402750
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

farrell90

Send PM Follow Ignore
Followers 134
Posts 3737
Boards Moderated 0
Alias Born 01/28/2006

farrell90

Member Level

Re: PJ007 post# 351749

Thursday, 03/11/2021 11:45:40 AM

Thursday, March 11, 2021 11:45:40 AM

Post# of 402750
If the phase 2 trials are positive you can expect an expanded compassionate use to be granted like it was for Remdesivir after their phase 2 trial. Many sick Covid patients are still not responding well to current standard of care.

Glta,
Farrell
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM

Start posting your company's news
Only $200 per official company press release!